Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesAbnormal findings on examination of urine, without diagnosisICD-10-CM r82-other-and-unspecified-urine-findings
    Ask Trek AI about this page

    ICD-10-CM Code For Other And Unspecified Abnormal Findings In Urine: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group R82 includes abnormal and unspecified findings on urine examination, such as abnormal constituents, sediment, or chemical results that do not yet have a confirmed diagnosis. These ICD-10-CM diagnosis codes are used to document clinical scenarios involving unexpected or unexplained urinalysis results, capturing aspects of disease detection, monitoring, or screening complexity. Accurate coding within the ICD-10-CM R82 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Other And Unspecified Abnormal Findings In Urine: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM R82: Other And Unspecified Abnormal Findings In Urine Overview

    The ICD-10-CM R82 group represents abnormal laboratory findings identified in urine testing that are not otherwise classified by a definitive diagnosis. These codes target urinary constituents and abnormalities detected on urinalysis, including substances, cells, and biochemical markers. Accurate coding matters for reimbursement because it documents the reason for testing and guides appropriate claim processing and clinical follow-up.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when urine testing reveals abnormal constituents, cells, or chemical results that are not explained by a confirmed urinary diagnosis. These codes are appropriate for documenting unexplained urinalysis abnormalities, screening findings, or when follow-up diagnostic clarification is pending.

    ICD-10-CM Codes

    18 rows

    ICD-10-CM CodeDescription
    R82.0Chyluria
    R82.1Myoglobinuria
    R82.2Biliuria
    R82.3Hemoglobinuria
    R82.4Acetonuria
    R82.5Elevated urine levels of drugs, medicaments and biological substances
    R82.6Abnormal urine levels of substances chiefly nonmedicinal as to source
    R82.71Bacteriuria
    R82.79Other abnormal findings on microbiological examination of urine
    R82.81Pyuria
    R82.89Other abnormal findings on cytological and histological examination of urine
    R82.90Unspecified abnormal findings in urine
    R82.91Other chromoabnormalities of urine
    R82.991Hypocitraturia
    R82.992Hyperoxaluria
    R82.993Hyperuricosuria
    R82.994Hypercalciuria
    R82.998Other abnormal findings in urine

    DRG Codes

    11 rows

    DRG CodeDescription
    441Disorders of Liver Except Malignancy, Cirrhosis or Alcoholic Hepatitis with MCC
    442Disorders of Liver Except Malignancy, Cirrhosis or Alcoholic Hepatitis with CC
    443Disorders of Liver Except Malignancy, Cirrhosis or Alcoholic Hepatitis without CC/MCC
    640Miscellaneous Disorders of Nutrition, Metabolism, Fluids and Electrolytes with MCC
    641Miscellaneous Disorders of Nutrition, Metabolism, Fluids and Electrolytes without MCC
    695Kidney and Urinary Tract Signs and Symptoms with MCC
    696Kidney and Urinary Tract Signs and Symptoms without MCC
    791Prematurity with Major Problems
    793Full Term Neonate with Major Problems
    947Signs and Symptoms with MCC
    948Signs and Symptoms without MCC

    Typical Clinical Scenarios

    • An adult presents to the emergency department with sudden onset flank pain and visible dark brown urine after vigorous exercise. Urinalysis in the ED shows marked myoglobinuria without clear evidence of hematuria or urinary tract infection; creatine kinase is elevated consistent with rhabdomyolysis, and the provider documents an abnormal urine pigment. A code from this group is assigned to capture the abnormal urine finding related to pigmenturia. Typical codes: R82.2, R82.3
    • A middle-aged outpatient with long‑standing diabetes has routine urinalysis that demonstrates persistent glycosuria despite near‑normal blood glucose readings and no prior diagnosis of gestational diabetes or overt hyperglycemia. The clinician documents an unexplained abnormal urinary constituent on laboratory testing and orders further metabolic workup; a code from this group is used to report the abnormal urinalysis finding. Typical codes: R82.4, R82.1
    • An elderly hospitalized patient develops new cloudy, foul‑smelling urine and a positive urine dipstick for protein and leukocyte esterase, but urine culture is negative or equivocal, and no definitive urinary tract infection is confirmed; the chart notes unspecified abnormal findings on urine microscopy. A code from this group is used to identify the abnormal urinalysis as a comorbidity affecting inpatient management while awaiting further diagnostic clarification. Typical codes: R82.81, R82.89

    Related Codes

    R80-PROTEINURIA

    ICD-10-CM Code For Proteinuria: Group Overview

    R81-GLYCOSURIA

    ICD-10-CM Code For Glycosuria: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.